These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3151354)

  • 1. Different activity of penicillins and cephalosporins on enterococci.
    Fontana R; Rossi L; Gesu GP; Maresu F; Satta G; Stefani S
    Chemioterapia; 1987 Jun; 6(2 Suppl):60-1. PubMed ID: 3151354
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of modern penicillins and cephalosporins against enterococci.
    Haller I; Heinrich S
    Arzneimittelforschung; 1982; 32(7):756-9. PubMed ID: 6812597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
    Chandrasekar PH; Price S; Levine DP
    J Antimicrob Chemother; 1985 Aug; 16(2):179-82. PubMed ID: 2933380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.
    Luther MK; Rice LB; LaPlante KL
    Antimicrob Agents Chemother; 2016 May; 60(5):3178-82. PubMed ID: 26926624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of azlocillin and other beta-lactam antibiotics against enterococci.
    Grimm H
    J Antimicrob Chemother; 1983 May; 11 Suppl B():43-9. PubMed ID: 6413483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of ampicillin plus ceftaroline is synergistic against Enterococcus faecalis.
    Werth BJ; Abbott AN
    J Antimicrob Chemother; 2015 Aug; 70(8):2414-7. PubMed ID: 25953804
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
    Frimodt-Møller N; Højbjerg T; Hvass E; Møller S; Mortensen I; Thomsen VF
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):181-8. PubMed ID: 3929558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the in vitro activity of 5 new antibiotics on strains isolated from urinary infections].
    Salvo S; Falcidia A; Mirone L
    Minerva Med; 1987 Jan; 78(2):71-7. PubMed ID: 3543744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The differentiation and sensitivity of enterococci to chemotherapeutics in urinary tract infections].
    Döll W; Bredt W
    Zentralbl Bakteriol Orig; 1968; 209(1):18-25. PubMed ID: 4988771
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children.
    Marks MI
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1137-44. PubMed ID: 4154827
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of media and blood on the antimicrobial activity of cephalosporins on serogroup D streptococci: a review.
    Thornsberry C; Sahm DF
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):75S-84S. PubMed ID: 6430633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefpirome (HR810) against Enterococcus species.
    Wheat PF; Spencer RC
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):235-7. PubMed ID: 2110905
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro activity of ampicillin-ceftriaxone against Enterococcus faecalis isolates recovered from invasive infections].
    Burguer Moreira N; Nastro M; Vay C; Famiglietti Á; Rodríguez CH
    Rev Argent Microbiol; 2016; 48(1):57-61. PubMed ID: 26857425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against enterococci.
    Chen HY; Williams JD
    J Antimicrob Chemother; 1983 Jul; 12(1):19-26. PubMed ID: 6413484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic post-antibiotic effect of amikacin and beta-lactam antibiotics on Enterococcus faecalis.
    Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
    J Antimicrob Chemother; 1991 May; 27 Suppl C():9-14. PubMed ID: 1906865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci.
    Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1997 Apr; 27(4):151-4. PubMed ID: 9154412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, clinical distribution, and susceptibility to several antibiotics of enterococci isolated in some Italian regions.
    Stefani S; Fontana R; Gesu G; Maida A; Nicoletti G; Pechmann A; Pompei R; Prenna M; Rossi L; Soro O
    Chemioterapia; 1987 Jun; 6(2 Suppl):22-3. PubMed ID: 3151343
    [No Abstract]   [Full Text] [Related]  

  • 20. The recent aspects of group D Streptococcus sensitivity to antibiotics.
    Turcu T; Mihalcu F; Cuciureanu G; Negurţ E; Stănescu C
    Arch Roum Pathol Exp Microbiol; 1981; 40(3):199-204. PubMed ID: 6800340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.